Gili Kenet

Tel Aviv University — Israel

Medicine · Health Sciences

50h-index10.1kcitations439works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood Coagulation and Thrombosis Mechanisms(165), Hemophilia Treatment and Research(154), Venous Thromboembolism Diagnosis and Management(83), Platelet Disorders and Treatments(77), Hemostasis and retained surgical items(27)

Publications432 total

Patients with Prior Cerebral Venous Sinus Thrombosis Presenting to the Emergency Department with Neurological Symptoms: The Yield of Neuroimaging
Acta Haematologica·2025Open Access
Endothelial protein C receptor–mediated endogenous and therapeutic transport of activated protein C across the blood–retina barrier protects the retina
Journal of Thrombosis and Haemostasis·2025
Experience with minor surgeries in people with hemophilia A or B with and without inhibitors receiving fitusiran
Blood·2025Open Access
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts
Pediatric Blood & Cancer·2025Open Access
Anticoagulation discharge treatment recommendations in patients admitted with a first-time diagnosis of atrial fibrillation
Postgraduate Medical Journal·2025
Recombinant Adeno-Associated Virus Integration Profiles in Nonhuman Primates and Gene Therapy Participants after Treatment with Valoctocogene Roxaparvovec
Human Gene Therapy·2025· 1 citedOpen Access
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial
The Lancet Haematology·2025· 3 cited
Hematological Evaluation and Management of Menorrhagia in Adolescents: Lessons from Adolescent Heavy Menstrual Bleeding Clinics
Acta Haematologica·2025· 1 citedOpen Access
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
Blood·2025· 21 citedOpen Access
Haemophilia
The Lancet·2025· 30 cited
Acquired Hemophilia—A Case Series and Review
Journal of Clinical Medicine·2025· 2 citedOpen Access
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec
Hämostaseologie·2025
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Hämostaseologie·2025· 1 cited
Direct oral anticoagulants in patients with severe inherited thrombophilia: Real-world data from a tertiary care center
Thrombosis Update·2025Open Access
Patients with Prior Cerebral Venous Sinus Thrombosis Presenting to the Emergency Department with Neurological Symptoms- The Yield of Neuroimaging
2025Open Access
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial
UNC Libraries·2024Open Access
A Novel Murine Model Rebalancing Coagulation Enables Gene Therapy Studies for Severe Protein C Deficiency, a Lethal Pro-Thrombotic Disorder
Blood·2024
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial
Research and Practice in Thrombosis and Haemostasis·2024· 25 citedOpen Access
EFFICACY AND SAFETY OF VALOCTOCOGENE ROXAPARVOVEC 4 YEARS AFTER GENE TRANSFER IN GENER8-1
Hematology Transfusion and Cell Therapy·2024Open Access
A Novel Murine Model Enabling rAAV8-PC Gene Therapy for Severe Protein C Deficiency
International Journal of Molecular Sciences·2024· 3 citedOpen Access
page 1 of 22Next →

Frequent Co-authors

Ulrike Nowak‐Göttl(16), Christoph Male(11), Paul Monagle(10), Guy Young(10), Neil A. Goldenberg(8), Susanne Holzhauer(8), Anthony K.C. Chan(7), Paolo Simioni(7), Karin Kurnik(6), Angelo Claudio Molinari(6), Leonardo R. Brandão(5), Marilyn J. Manco‐Johnson(5), Rolf Ljung(5), Pascal Amédro(5), Christoph Bidlingmaier(5), U. Martinowitz(4), Christine Heller(4), Ralf Junker(4), C. Heleen van Ommen(4), Elena Santagostino(4)